Evaluation the effect of several anticancer drugs on Vietnamese breast cancer cells

O. Nguyen
{"title":"Evaluation the effect of several anticancer drugs on Vietnamese breast cancer cells","authors":"O. Nguyen","doi":"10.32508/stdj.v21i2.488","DOIUrl":null,"url":null,"abstract":"In Viet Nam, data from Conference of Cancer organized by the Ministry of Health has shown that breast cancer is the most popular cancer in women. Current mainly treatments are surgery, chemotherapy, and radiotherapy. However, the rate of recurrence after five years was very high. One of the causes of high relapse is cancer cells develop multidrug-resistant (MDR) thus reduced the efficiency of treatments. In this research, MTT assay was used for measured cell viability of Vietnamese breast cancer cells (VNBRCA cells) and positive control MCF-7 cell lines after treatment with several anticancer drugs as Doxorubicin (DOX), Tamoxifen (TAM), Mitomycin C (MMC) in 48h. After that, cancer cells were treated at haft maximal inhibitory concentration (IC50) of anticancer drug and observed cell morphology, apoptosis of cellular nuclear by AO/PI staining. IC50 value of VNBRCA cells with DOX, TAM, MMC were 0.641± 0.07 µM, 4.639 ± 0.933 µM and 1.338 ± 0.176 µM, respectively, which higher than IC50 of MCF-7 with DOX, TAM, MMC was 0.168 ± 0.037 µM, 7.085 ± 0.87 µM and 0.379 ± 0.159 µM, respectively. The response of VNBRCA cells with several anticancer drugs as DOX, TAM, and MMC was lower than the response of MCF-7, therefore, it showed that the specific features of VNBRCA cells; from which develop specific treatments for Vietnamese breast cancer patients.","PeriodicalId":285953,"journal":{"name":"Science and Technology Development Journal","volume":"185 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science and Technology Development Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32508/stdj.v21i2.488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

In Viet Nam, data from Conference of Cancer organized by the Ministry of Health has shown that breast cancer is the most popular cancer in women. Current mainly treatments are surgery, chemotherapy, and radiotherapy. However, the rate of recurrence after five years was very high. One of the causes of high relapse is cancer cells develop multidrug-resistant (MDR) thus reduced the efficiency of treatments. In this research, MTT assay was used for measured cell viability of Vietnamese breast cancer cells (VNBRCA cells) and positive control MCF-7 cell lines after treatment with several anticancer drugs as Doxorubicin (DOX), Tamoxifen (TAM), Mitomycin C (MMC) in 48h. After that, cancer cells were treated at haft maximal inhibitory concentration (IC50) of anticancer drug and observed cell morphology, apoptosis of cellular nuclear by AO/PI staining. IC50 value of VNBRCA cells with DOX, TAM, MMC were 0.641± 0.07 µM, 4.639 ± 0.933 µM and 1.338 ± 0.176 µM, respectively, which higher than IC50 of MCF-7 with DOX, TAM, MMC was 0.168 ± 0.037 µM, 7.085 ± 0.87 µM and 0.379 ± 0.159 µM, respectively. The response of VNBRCA cells with several anticancer drugs as DOX, TAM, and MMC was lower than the response of MCF-7, therefore, it showed that the specific features of VNBRCA cells; from which develop specific treatments for Vietnamese breast cancer patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
几种抗癌药物对越南乳腺癌细胞影响的评价
在越南,卫生部组织的癌症会议的数据表明,乳腺癌是妇女中最常见的癌症。目前主要的治疗方法有手术、化疗和放疗。然而,5年后的复发率非常高。复发率高的原因之一是癌细胞产生多药耐药(MDR),从而降低了治疗效率。本研究采用MTT法测定越南乳腺癌细胞(VNBRCA细胞)和阳性对照MCF-7细胞株在多柔比星(DOX)、他莫昔芬(TAM)、丝裂霉素C (MMC)等多种抗癌药物治疗48h后的细胞活力。然后以抗癌药物的半数最大抑制浓度(IC50)处理癌细胞,AO/PI染色观察细胞形态、细胞核凋亡情况。DOX、TAM、MMC对VNBRCA细胞的IC50分别为0.641±0.07µM、4.639±0.933µM和1.338±0.176µM,高于DOX、TAM、MMC对MCF-7细胞的IC50分别为0.168±0.037µM、7.085±0.87µM和0.379±0.159µM。VNBRCA细胞对DOX、TAM、MMC等几种抗癌药物的反应低于MCF-7的反应,因此,显示了VNBRCA细胞的特异性;开发针对越南乳腺癌患者的特殊治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Identification of commensal Pseudomonas aeruginosa isolates using duplex PCR targeting the oprL and algD genes P2- a2=3Mn2=3M1=3O2 (M = Fe, Co, Ni) cathode materials in localized high concentration electrolyte for the long-cycling performance of sodium-ion batteries Gold nanoparticles enhanced fluorescence for highly sensitive biosensors based on localized surface plasmon resonance applied in determination C-reactive protein Two new compounds from leaves of Bruguiera cylindrica (L.) Blume with the in vitro α-glucosidase inhibitory activity Postharvest responses of Carnation cut flowers to Prunus cerasoides mediated silver nanoparticles
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1